Library
25P-NBOMe
A rare potent psychedelic drug with similar effects and risks to others in the NBOMe class. Yet no trip reports... when the substance was first sold in mid-late 2012, and resurfaced in early 2015.
Also known as: NBOMe-2C-P, 25P, P‑NBOMe
Classification
- Chemical: Phenethylamine
- Psychoactive: Psychedelic
- Tag: Research-Chemical
- Tag: Tentative
Effects
- Mentalphysical Stimulation
- Decreased Appetite
- Pupil Dilation
- Restlessness
- Sweatingchills
- Muscle Tension
- Euphoria
- Empathy
- Insight
- Change In Perception
- Ego Softening
- Confusion
- Brightened Color
- Closedopen Eye Visuals
- Enhanced Tactile Sensation
- Closed Eye Visuals
- Open Eye Visuals
- Color Enhancement
Routes of Administration
Oral
Dosage
- Common: 450-700 ug
- Light: 250-450 ug
- Strong: 700-1500 ug
- Threshold: 100-250 ug
Duration
No data available for this section yet.
Sublingual
Dosage
- Heavy: 900+ µg
- Light: 100–250 µg
- Common: 250–600 µg
- Strong: 600–900 µg
- Threshold: 50–100 µg
Duration
- Onset: 0.17-0.5 h
- Peak: 2-5 h
- Offset: 4-8 h
- After Effects: 2-6 h
- Total Duration: 8-14 h
Insufflated
Dosage
- Heavy: 450+ µg
- Light: 50–120 µg
- Common: 120–300 µg
- Strong: 300–450 µg
- Threshold: 25–50 µg
Duration
- Onset: 0.08-0.33 h
- Peak: 1.5-4 h
- Offset: 2-5 h
- After Effects: 1-6 h
- Total Duration: 6-12 h
Vaporized
Dosage
- Heavy: 300+ µg
- Light: 40–80 µg
- Common: 80–200 µg
- Strong: 200–300 µg
- Threshold: 20–40 µg
Duration
- Onset: 0.03-0.08 h
- Peak: 1-3 h
- Offset: 2-5 h
- After Effects: 1-6 h
- Total Duration: 6-12 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.